Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT02655302
NA

Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD

Sponsor: University Hospital, Lille

View on ClinicalTrials.gov

Summary

Chronic obstructive pulmonary disease (COPD) is a worldwide chronic inflammatory disease of the airways linked to environmental exposure. The chronic course of COPD is often interrupted by acute exacerbations which have a major impact on the morbidity and mortality of COPD patients. A bacterial etiology for these exacerbations is common (almost 50%). Moreover, airway bacterial colonization linked to an increased susceptibility is observed in COPD patients. Effective Th17 immune response is needed to develop a good response against bacteria. Thus, this study aims to demonstrate that there is a defective IL-17/ IL-22 response to bacteria in COPD leading to airway bacterial colonization and infection.

Key Details

Gender

All

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2018-07-04

Completion Date

2028-07

Last Updated

2023-01-27

Healthy Volunteers

No

Interventions

OTHER

Sample collecting

Collect sputum, blood and nasopharyngeal swab during the exacerbation and at steady state 8 to 16 weeks later.

OTHER

Lung function measure

Measure lung function and follow it during 4 years

Locations (4)

University hospital of Lille

Lille, France

Roubaix hospital

Roubaix, France

Seclin hospital

Seclin, France

Tourcoing hospital

Tourcoing, France